S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Disc Medicine Inc (IRON)
Disc Medicine Inc (IRON) News

IRON

Disc Medicine (IRON)

Disc Medicine Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IRON

1 2 3 4 5 Next >>

Date	Time	Source	Headline	Symbol	Company
04/01/2024	7:00AM	GlobeNewswire Inc.	Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)	NASDAQ:IRON	Disc Medicine Inc
03/21/2024	7:00AM	GlobeNewswire Inc.	Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:IRON	Disc Medicine Inc
03/06/2024	3:30PM	GlobeNewswire Inc.	Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024	NASDAQ:IRON	Disc Medicine Inc
03/01/2024	6:49PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
03/01/2024	6:39PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
03/01/2024	6:38PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
03/01/2024	6:36PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
02/26/2024	7:43AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IRON	Disc Medicine Inc
02/26/2024	7:30AM	GlobeNewswire Inc.	Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer	NASDAQ:IRON	Disc Medicine Inc
02/20/2024	7:30AM	GlobeNewswire Inc.	Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease	NASDAQ:IRON	Disc Medicine Inc
02/15/2024	3:22PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
02/13/2024	5:51PM	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:IRON	Disc Medicine Inc
02/09/2024	8:00AM	GlobeNewswire Inc.	Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia Vera	NASDAQ:IRON	Disc Medicine Inc
02/07/2024	7:10AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IRON	Disc Medicine Inc
02/07/2024	7:00AM	GlobeNewswire Inc.	Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating Officer	NASDAQ:IRON	Disc Medicine Inc
02/06/2024	3:55PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
01/23/2024	4:48PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
01/04/2024	3:24PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
01/03/2024	4:00PM	GlobeNewswire Inc.	Disc Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:IRON	Disc Medicine Inc
01/03/2024	3:18PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
01/02/2024	3:30PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
12/29/2023	3:15PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
12/20/2023	3:30PM	GlobeNewswire Inc.	Disc Medicine Announces Retirement of Brian MacDonald, MB, ChB, PhD as Chief Innovation Officer and Appointment as Chair of Scientific Advisory Board	NASDAQ:IRON	Disc Medicine Inc
12/14/2023	3:15PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
12/12/2023	3:19PM	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRON	Disc Medicine Inc
12/11/2023	7:30PM	GlobeNewswire Inc.	Disc Presents Positive Updated Results from Phase 2 BEACON Study of Bitopertin and Other Programs at the 65th American Society of Hematology (ASH) Annual Meeting	NASDAQ:IRON	Disc Medicine Inc
12/11/2023	11:11AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IRON	Disc Medicine Inc
12/11/2023	11:00AM	GlobeNewswire Inc.	Disc Presents Initial Positive Data from Ongoing Phase 1b/2 Trial of DISC-0974 in Patients with Myelofibrosis (MF) and Anemia at the 65th American Society of Hematology (ASH) Annual Meeting	NASDAQ:IRON	Disc Medicine Inc
12/07/2023	3:15PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRON	Disc Medicine Inc
12/06/2023	11:15PM	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:IRON	Disc Medicine Inc

Showing the most relevant articles for your search:NASDAQ:IRON

1 2 3 4 5 Next >>

Greene Concepts (PK)

Movement Industries (PK)

Kraig Biocraft Laborator... (QB)

TheGlobe com (PK)

Therapeutic Solutions (PK)

Mullen Automotive

Innerscope Hearing Techn... (PK)

Elite Pharmaceuticals (QB)

Digital Brand Media and ... (PK)

Alternet Systems (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions